Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Clinical trial NCT04405622 · UNKNOWN

Trial details

NCT number: NCT04405622
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma Recurrent Nasopharyngeal Carcinoma Metastatic Nasopharyngeal Carcinoma Chemotherapy Effect Immunotherapy

Start date: 2020-05-30
Primary completion: 2023-03-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.